Metabolic disease
Conditions
Interventions
A:Sodium lactate Ringer solution+arterial blood pressure oriented liquid therapy
B:Sodium lactate Ringer solution+Vigileo monitoring liquid therapy
C:Ringer solution of sodium bicarbonate+arterial blood pressure oriented liquid therapy
D:Ringer solution of sodium bicarbonate+Vigileo monitoring liquid therapy
Sponsors
Affiliated Hospital of Xuzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients to undergo weight reduction surgery; (2) 18-65 years old, regardless of gender; (3) ASA Class I-II; (4) Informed consent, voluntarily participate in the test and sign the informed consent form
Exclusion criteria
Exclusion criteria: (1) Patients with serious heart, brain, lung, liver, kidney and metabolic diseases; (2) Previous history of abnormal surgical anesthesia recovery; (3) ECG showed that the heart rate was100 times/min; (4) Systolic blood pressure>180mmHg and/or diastolic blood pressure>110mmHg in patients with hypertension or40%); (8) Subjects who are not suitable to participate in this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Arterial blood gas analysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood pressure;heart rate;SpO2;PetCO2;TNF-a;IL-1ß;IL-6;TGF-ß; | — |
Countries
China
Contacts
Public ContactZhiping Wang
Affiliated Hospital of Xuzhou Medical University
Outcome results
None listed